[go: up one dir, main page]

UY33394A - PHARMACEUTICAL COMPOSITION OF IBUPROFEN FOR INJECTION - Google Patents

PHARMACEUTICAL COMPOSITION OF IBUPROFEN FOR INJECTION

Info

Publication number
UY33394A
UY33394A UY0001033394A UY33394A UY33394A UY 33394 A UY33394 A UY 33394A UY 0001033394 A UY0001033394 A UY 0001033394A UY 33394 A UY33394 A UY 33394A UY 33394 A UY33394 A UY 33394A
Authority
UY
Uruguay
Prior art keywords
ibuprofen
injection
pharmaceutical composition
containers
autoclaving
Prior art date
Application number
UY0001033394A
Other languages
Spanish (es)
Inventor
Ignacio Ortuzar Andechaga
Mario Ortuzar Gutierrez
Original Assignee
Spain Pharma S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spain Pharma S A filed Critical Spain Pharma S A
Publication of UY33394A publication Critical patent/UY33394A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Composición farmacéutica de ibuprofeno para inyección que comprende una solución acuosa de ibuprofeno y trometamol. Estas composiciones exhiben una pérdida de principio activo mínima y una producción de impurezas aceptable tras el autoclavado, propiedades que han sido demostradas en distintos tipos de envases, tales como envases de material plástico del tipo polipropileno, PVC y polietileno, así como en envases de vidrio. Estas composiciones, tras haber sido sometidas a autoclavado, siguen cumpliendo todas las especificaciones técnicas correspondientes de la Farmacopea Europea y de la de EE.UU.Pharmaceutical composition of ibuprofen for injection comprising an aqueous solution of ibuprofen and trometamol. These compositions exhibit a minimum loss of active ingredient and acceptable impurity production after autoclaving, properties that have been demonstrated in different types of containers, such as polypropylene, PVC and polyethylene type plastic material containers, as well as in glass containers . These compositions, after being subjected to autoclaving, continue to meet all the corresponding technical specifications of the European Pharmacopoeia and that of the USA.

UY0001033394A 2010-05-18 2011-05-17 PHARMACEUTICAL COMPOSITION OF IBUPROFEN FOR INJECTION UY33394A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES2010007330 2010-05-18

Publications (1)

Publication Number Publication Date
UY33394A true UY33394A (en) 2011-12-01

Family

ID=45023413

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001033394A UY33394A (en) 2010-05-18 2011-05-17 PHARMACEUTICAL COMPOSITION OF IBUPROFEN FOR INJECTION

Country Status (1)

Country Link
UY (1) UY33394A (en)

Similar Documents

Publication Publication Date Title
ECSP12012274A (en) PHARMACEUTICAL COMPOSITION OF IBUPROFEN FOR INJECTION
MX385876B (en) PHARMACEUTICAL COMPOSITION COMPRISING AMORPHOUS LENALIDOMIDE AND AN ANTIOXIDANT.
CL2014000670A1 (en) Bottle closure comprising a bimodal polyethylene composition; process for the preparation of the closure; process to prepare a polyethylene composition; and composition of bimodal polyethylene.
DOP2015000006A (en) ETANERCEPT FORMULATIONS SHOWING A MARKING REDUCTION OF THE AMOUNT OF SUBVISIBLE PARTICLES
IL259414B (en) Piperazine-2,5-dione derivatives, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
MX375001B (en) DEXMEDETOMIDINE PREMIX FORMULATION.
CO7190242A2 (en) Nuclear transport modulators and their uses
TR201905586T4 (en) FORMULATIONS CONTAINING AMORF DAPAGLIFLOZINE
CR20190331A (en) A CRYSTAL FORM A OF AN ANDROGEN RECEPTOR MODULATOR (Divisional 2014-0549)
AR084057A1 (en) COMPOSITIONS FOR FABRIC CARE
BR112015009228A8 (en) STERILE LIQUID PHARMACEUTICAL FORMULATION AND STERILE LIQUID OPHTHALMIC INTRAOCULAR DOSAGE FOR INJECTION
HK1221418A1 (en) Hydrogel-linked prodrugs releasing modified drugs
BR112015010271A2 (en) comicronization product, pharmaceutical composition and its uses
TN2015000267A1 (en) Solid unit with high fexofenadine content and process for the preparation thereof
IN2015DN02999A (en)
ECSP10010153A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING BRADIQUININE ANTAGONISTS AND HIALURONIC ACID AND ITS USES
AR093252A1 (en) ORAL PHARMACEUTICAL COMPOSITION USED AS ANTIPARASITARY AND ANTIDIARRICS AND PROCESSES TO PREPARE IT
AR094224A1 (en) PHARMACEUTICAL COMPOSITION IN THE FORM OF AN ORAL SUSPENSION
UY33394A (en) PHARMACEUTICAL COMPOSITION OF IBUPROFEN FOR INJECTION
ECSP15005163A (en) PEDIATRIC ORAL LIQUID COMPOSITIONS CONTAINING NEPADUTANT
AR099340A1 (en) CONJUGATES OF THE COAGULATION FACTOR IX
MX2020004545A (en) Crystalline salt of a tricyclic poly(adp-ribose) polymerase inhibitor.
AR115942A2 (en) STABLE PHARMACEUTICAL COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF ARISULFATASE A AND CONTAINING CONTAINERS
BR112014032033A2 (en) formulations for the preparation of oral immediate release tablets containing a low dosage of mifepristone, tablets thereby obtained and their preparation process
CO2018005367A2 (en) Pharmaceutical composition containing, as active ingredient, derivative of 7-azaindolin-2-one or pharmaceutically acceptable salt of the same technical field